Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis - Université de Reims Champagne-Ardenne
Journal Articles Journal of Cystic Fibrosis Year : 2021

Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis

Philippe Reix
Aurélie Tatopoulos
  • Function : Author
Iulia Ioan
  • Function : Author
Muriel Le Bourgeois
  • Function : Author
Stéphanie Bui
  • Function : Author
Marie Luce Choukroun
  • Function : Author
Katia Bessaci-Kabouya
  • Function : Author
Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250
Michele Gerardin
  • Function : Author
Plamen Bokov
  • Function : Author
Jennifer da Silva
  • Function : Author
Jean-Louis Paillasseur
  • Function : Author
Pierre Regis Burgel

Domains

Life Sciences [q-bio]
Fichier principal
Vignette du fichier
S1569199321012868.pdf (441.11 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Accord Elsevier CCSD  : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03330701

Submitted on : Monday, July 22, 2024-11:08:48 AM

Last modification on : Monday, July 22, 2024-11:08:49 AM

Download

Dates and versions

hal-03330701 , version 1 (22-07-2024)

Licence

Attribution - NonCommercial

Identifiers

Elsevier-hosted Accepted Manuscript

Cite

Philippe Reix, Aurélie Tatopoulos, Iulia Ioan, Muriel Le Bourgeois, Stéphanie Bui, et al.. Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis, 2021, ⟨10.1016/j.jcf.2021.06.002⟩. ⟨hal-03330701⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

URCA P3CELL
63 View
4 Download

Altmetric

Share

More